Constitutive RET tyrosine kinase activation in hereditary medullary thyroid cancer: clinical opportunities
- 10 June 2009
- journal article
- review article
- Published by Wiley in Journal of Internal Medicine
- Vol. 266 (1), 114-125
- https://doi.org/10.1111/j.1365-2796.2009.02113.x
Abstract
The ground-breaking discovery of genotype-phenotype relationships in hereditary medullary thyroid cancer has greatly facilitated early prophylactic thyroidectomy. Its timing depends not solely on a positive gene test but, more importantly, on the type of the REarranged during Transfection (RET) mutation and its underlying mode of RET receptor tyrosine kinase activation. In the past decade, the therapeutic corridor opened by molecular information has been defined down to a remarkable level of detail. Based on mutational risk profiles, preemptive thyroidectomy is recommended at 6 months of age for carriers of highest-risk mutations, before the age of 5 years for carriers of high-risk mutations, and before the age of 5 or 10 years for carriers of least-high-risk mutations. Additional lymph node dissection may not be needed in the absence of increased preoperative basal calcitonin levels. Better comprehension of RET function should enable the design of targeted therapies for RET carriers beyond surgical cure in whom the DNA-based 'window of opportunity' has been missed.Keywords
This publication has 84 references indexed in Scilit:
- Difference in development of medullary thyroid carcinoma among carriers of RET mutations in codons 790 and 791*Clinical Endocrinology, 2008
- RET Proto-Oncogene in Sardinia: V804M Is the Most Frequent Mutation and May Be Associated with FMTC/MEN-2A PhenotypeThyroid®, 2007
- Self-association of the transmembrane domain of RET underlies oncogenic activation by MEN2A mutationsOncogene, 2006
- Inherited Medullary Thyroid Cancer and the Duty to Warn: Revisiting Pate v. Threlkel in Light of HIPAAThyroid®, 2005
- Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysisCancer, 2000
- Mechanism of Ret Activation by a Mutation at Aspartic Acid 631 Identified in Sporadic PheochromocytomaBiochemical and Biophysical Research Communications, 1999
- Genetic Alterations of the RET Proto-Oncogene in Familial and Sporadic PheochromocytomasHormone Research, 1997
- Early presentation of metastatic medullary carcinoma in multiple endocrine neoplasia, type IIA: Implications for therapyThe Journal of Pediatrics, 1996
- Detection of Ret Homodimers in MEN 2A-Associated PheochromocytomasBiochemical and Biophysical Research Communications, 1996
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences of the United States of America, 1971